FST | Follistatin | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FTH1 | Ferritin, heavy polypeptide 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
FTL | Ferritin, light polypeptide | Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
GFAP | Glial fibrillary acidic protein | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | | | Tissue enriched |
GGT1 | Gamma-glutamyltransferase 1 | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GH1 | Growth hormone 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
GOT2 | Glutamic-oxaloacetic transaminase 2, mitochondrial | Cancer-related genes Candidate cardiovascular disease genes Enzymes Mitochondrial proteins Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
HABP2 | Hyaluronan binding protein 2 | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
HEXA | Hexosaminidase A (alpha polypeptide) | Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
HGF | Hepatocyte growth factor (hepapoietin A; scatter factor) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
HP | Haptoglobin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
HPX | Hemopexin | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
ICAM1 | Intercellular adhesion molecule 1 | Cancer-related genes Candidate cardiovascular disease genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
IGF1 | Insulin-like growth factor 1 (somatomedin C) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
IGFBP1 | Insulin-like growth factor binding protein 1 | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
IL10 | Interleukin 10 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
IL18 | Interleukin 18 (interferon-gamma-inducing factor) | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins
| | | | | Expressed in all |
IL1RL1 | Interleukin 1 receptor-like 1 | Candidate cardiovascular disease genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
IL1RN | Interleukin 1 receptor antagonist | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IL2 | Interleukin 2 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Not detected |
IL6 | Interleukin 6 (interferon, beta 2) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IL6ST | Interleukin 6 signal transducer (gp130, oncostatin M receptor) | Cancer-related genes Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
IL8 | Interleukin 8 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
INHBA | Inhibin, beta A | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
INS | Insulin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
ITGA2B | Integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
LCN2 | Lipocalin 2 | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LEP | Leptin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
LEPR | Leptin receptor | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
LPA | Lipoprotein, Lp(a) | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
LPL | Lipoprotein lipase | Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
LRP1 | Low density lipoprotein receptor-related protein 1 | Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
MAPT | Microtubule-associated protein tau | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins
| | | | | Tissue enhanced |
MB | Myoglobin | Candidate cardiovascular disease genes Plasma proteins
| | | | | Group enriched |
MBP | Myelin basic protein | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | | | Tissue enriched |
MME | Membrane metallo-endopeptidase | Cancer-related genes Candidate cardiovascular disease genes CD markers Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MMP2 | Matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MMP3 | Matrix metallopeptidase 3 (stromelysin 1, progelatinase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MMP9 | Matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MPO | Myeloperoxidase | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
MYH11 | Myosin, heavy chain 11, smooth muscle | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | | | Mixed |
MYH6 | Myosin, heavy chain 6, cardiac muscle, alpha | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | | | Tissue enriched |
MYH7 | Myosin, heavy chain 7, cardiac muscle, beta | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | | | Group enriched |
MYL2 | Myosin, light chain 2, regulatory, cardiac, slow | Candidate cardiovascular disease genes Cytoskeleton related proteins Disease related genes
| | | | | Group enriched |
MYL3 | Myosin, light chain 3, alkali; ventricular, skeletal, slow | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | | | Group enriched |
NPPA | Natriuretic peptide A | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
NPPB | Natriuretic peptide B | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ORM1 | Orosomucoid 1 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
PAPPA | Pregnancy-associated plasma protein A, pappalysin 1 | Cancer-related genes Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PDGFA | Platelet-derived growth factor alpha polypeptide | Cancer-related genes Candidate cardiovascular disease genes Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |